The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers
(By Arthur Allen for KFF Health News) The first drug purporting to slow the advance of Alzheimer’s disease is likely
Read More
Medicare Part D
CMS projects slightly lower Medicare Part D premiums in 2024
(By Rylee Wilson for Becker’s Hospital Review) CMS is projecting Medicare Part D premiums to decrease by 1.8 percent in
Read MoreHow Do Dual-Eligible Individuals Get Their Medicare Coverage?
(By Maria T. Peña, Maiss Mohamed, Jeannie Fuglesten Biniek, Juliette Cubanski, and Tricia Neuman for Kaiser Family Foundation Published: Jul
Read MoreWhat’s a fair price for a prescription drug? Medicare’s about to weigh in
(By Leslie Walker and Dan Gorenstein for NPR) Drugmakers around the globe are bracing for a major shakeup in how
Read MoreKey Facts About Medicare Part D Enrollment and Costs in 2023
(By Juliette Cubanski and Anthony Damico for Kaiser Family Foundation Published: Jul 26, 2023) The Medicare Part D program provides
Read MoreNew Weight Loss Drugs Carry High Price Tags and Lots of Questions for Seniors
(By Judith Graham for KFF Health News) Corlee Morris has dieted throughout her adult life. After her weight began climbing
Read MoreAn experimental Alzheimer’s drug outperforms one just approved by the FDA
(By Jon Hamilton for NPR) Patients in the early stages of Alzheimer’s may soon have a new option to stave
Read MoreWill the new Alzheimer’s drug put pressure on Medicare premiums?
The FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read More10 Prescription Drugs Accounted for $48 Billion in Medicare Part D Spending in 2021, or More Than One-Fifth of Part D Spending That Year
(By Chris Lee for The Kaiser Family Foundation published July 12, 2023) A new KFF analysis finds that the 10
Read MoreHHS Announces Actions to Protect Consumers and Lower Health Care Costs
(Source – www.cms.gov/newsroom) The U.S. Department of Health and Human Services (HHS), announced actions to protect consumers from junk health
Read More